BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36966665)

  • 1. Puerarin: a potential natural neuroprotective agent for neurological disorders.
    Liu X; Huang R; Wan J
    Biomed Pharmacother; 2023 Jun; 162():114581. PubMed ID: 36966665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rd: A promising natural neuroprotective agent.
    Chen YY; Liu QP; An P; Jia M; Luan X; Tang JY; Zhang H
    Phytomedicine; 2022 Jan; 95():153883. PubMed ID: 34952508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress on the pharmacological research of puerarin: a review.
    Wei SY; Chen Y; Xu XY
    Chin J Nat Med; 2014 Jun; 12(6):407-14. PubMed ID: 24969520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
    Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
    Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puerarin: a review of pharmacological effects.
    Zhou YX; Zhang H; Peng C
    Phytother Res; 2014 Jul; 28(7):961-75. PubMed ID: 24339367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerarin: A review of its mechanisms of action and clinical studies in ophthalmology.
    Meng F; Guo B; Ma YQ; Li KW; Niu FJ
    Phytomedicine; 2022 Dec; 107():154465. PubMed ID: 36166943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways.
    Zhang H; Liu Y; Lao M; Ma Z; Yi X
    Exp Gerontol; 2011 Jan; 46(1):30-7. PubMed ID: 20933077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
    Chen X; Yu J; Shi J
    Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice.
    Zhu G; Wang X; Wu S; Li X; Li Q
    Phytother Res; 2014 Feb; 28(2):179-86. PubMed ID: 23512787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.
    Chauhan P; Wadhwa K; Mishra R; Gupta S; Ahmad F; Kamal M; Iqbal D; Alsaweed M; Nuli MV; Abomughaid MM; Almutary AG; Mishra PC; Jha SK; Ojha S; Nelson VK; Dargar A; Singh G; Jha NK
    Mol Neurobiol; 2024 May; ():. PubMed ID: 38780722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.
    Liu T; Su K; Cai W; Ao H; Li M
    Eur J Pharmacol; 2023 Aug; 953():175695. PubMed ID: 36977450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerarin may protect against Schwann cell damage induced by glucose fluctuation.
    Xue B; Wang L; Zhang Z; Wang R; Xia XX; Han PP; Cao LJ; Liu YH; Sun LQ
    J Nat Med; 2017 Jul; 71(3):472-481. PubMed ID: 28181078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway.
    Zou Y; Hong B; Fan L; Zhou L; Liu Y; Wu Q; Zhang X; Dong M
    Free Radic Res; 2013 Jan; 47(1):55-63. PubMed ID: 23088308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
    Zamanian MY; Kujawska M; Nikbakhtzadeh M; Hassanshahi A; Ramezanpour S; Kamiab Z; Bazmandegan G
    CNS Neurol Disord Drug Targets; 2021; 20(10):942-953. PubMed ID: 33970850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.
    Yu CC; Du YJ; Li J; Li Y; Wang L; Kong LH; Zhang YW
    Aging Dis; 2022 Jul; 13(4):1092-1105. PubMed ID: 35855345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Puerarin against Aβ 1-42-Induced Learning and Memory Impairments in Mice.
    Wu L; Tong T; Wan S; Yan T; Ren F; Bi K; Jia Y
    Planta Med; 2017 Feb; 83(3-04):224-231. PubMed ID: 27420352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway.
    Xing G; Dong M; Li X; Zou Y; Fan L; Wang X; Cai D; Li C; Zhou L; Liu J; Niu Y
    Brain Res Bull; 2011 May; 85(3-4):212-8. PubMed ID: 21473901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constituent isoflavones of Puerariae radix as a potential neuroprotector in cognitive impairment: Evidence from preclinical studies.
    Ren Y; Qu S
    Ageing Res Rev; 2023 Sep; 90():102040. PubMed ID: 37619620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.